Target intelligence / Profile preview

microRNA 16-1 (miR-16)

Target: miR-16
Molecular classification: microRNA, non-coding RNA

Overview

microRNA-16 (miR-16) is a small, non-coding RNA molecule that plays a crucial role in regulating gene expression by targeting specific messenger RNAs (mRNAs), thereby influencing biological processes such as cell cycle progression and apoptosis. It acts as a tumor suppressor in cancers like chronic lymphocytic leukemia (CLL) and is involved in fibrotic diseases by modulating the extracellular matrix synthesis.

Other names: miR-16-5pMIR16-1

Mechanism of action

miR-16 mimics act by enhancing the degradation of targeted mRNAs, such as oncogenes, thereby inhibiting cancer cell proliferation and promoting apoptosis.

Biological functions

Regulation of gene expression by targeting multiple mRNAs, leading to mRNA degradation or translational repression.Influence on cell cycle progression by targeting genes involved in cell cycle checkpoints.Promotion of apoptosis in cancer cells by targeting anti-apoptotic genes.Modulation of immune responses indirectly through its effects on cellular processes.

Disease associations

Acts as a tumor suppressor by targeting oncogenes and promoting apoptosis in cancer cells.Plays a role in fibrosis by regulating the synthesis and degradation of extracellular matrix in various organs.

Safety considerations

Potential for off-target effects due to the non-specific binding of miRNA mimics to unintended mRNAs.Difficulty in delivering miRNA mimics to target tissues or cells.

Interacting drugs

miR-16 mimics

Biomarkers

No specific biomarkers are widely recognized for miR-16 itself, but it may be used as a biomarker for certain diseases, such as cancer, by measuring its expression levels.

Beyond the preview

Go deeper on microRNA 16-1 (miR-16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 16-1 (miR-16).

Explore the full profile